ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS

• What Is The Suvoda Platform?

  If you're ready to streamline your clinical trials and deliver better outcomes for all stakeholders, explore how the Suvoda Platform can transform your trial experience today.

• Crowdsource UAT: An Opportunity For Future Validation

  IQVIA, a leading health information technology and clinical research company, has introduced a new validation model for eTMF patterned after approaches used within the larger tech space.

• The Digital Teammate: How AI Is Changing Clinical Research

  AI in clinical research serves as a "digital colleague," enhancing workflows, accelerating data analysis, and empowering study teams with precision, and insightful solutions for better patient outcomes.

• AI-Powered Breakthroughs In CNS And Pain Trials

  Discover how AI-powered tools like EEG are revolutionizing neurological and pain clinical trials by replacing subjectivity with precision and drastically accelerating the path to approval.

• How Are You Labeling Your IP? Protect Your Clinical Trial With Distinct Treatment Numbers

  Explore why engaging randomization and trial supply management (RTSM) services early in study startup can help protect clinical trials and expose substantial efficiencies, effectively baking in practices that help streamline supply chains.

• Ensuring Patient-Centered Care In Oncology Trials

  In oncology trials, safety and tolerability are a core focus. From centralized ECGs to patient-reported outcomes, utilize this guide for optimizing assessments of drug safety and quality of life.

• A Leading Academic Medical Center Monitors Newly Diagnosed Myeloma Patients

  Learn how eCOA helped to motivate patients and increased engagement around experiences outside of the clinical setting, which otherwise may have gone unmentioned.

• The Strategic Role Of KOLs In Rare Disease Drug Development

  Engaging key Opinion Leaders (KOL) is crucial for accelerating rare disease research breakthroughs. However, identifying the right experts is challenging due to fragmented data and evolving expertise.

• Digital Outcome Measures Approved As Primary Endpoint In Cardiopulmonary Study

  Discover how a clinical development program was saved using objective, continuous digital outcome measures.

• 5 Features to Look for in Your Next eTMF

  Not every electronic trial master file will provide the robust support and compliance measures required. When searching for a successful solution, make sure the eTMF of interest has these five features.